Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno/LinkedIn
May 5, 2026, 13:20

Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status

Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at Gunma University Hospital, shared a post on LinkedIn:

“A bit delayed, but I had the privilege of attending ACC.26 in New Orleans last month.

I presented our analysis from the COMMAND VTE Registry-2 examining management and outcomes of venous thromboembolism (VTE) across renal function and hemodialysis status.

A key takeaway: bleeding risk in VTE patients is not driven by eGFR alone—being on hemodialysis itself confers additional bleeding risk, beyond what renal function metrics capture.

This nuance matters when we counsel patients on anticoagulation strategy.

It was also my first time in New Orleans, and the jazz culture was a wonderful surprise.

I’d love to go back.

Grateful to all collaborators in the COMMAND VTE Registry-2 investigators group, and to my mentors for their guidance.”

Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status

Stay updated with Hemostasis Today.

ACC.26 bleeding disorders Hematology Hemodialysis Hemostasis Hemostasis News Hemostasis Today Medicine Takahiro Kuno thrombosis venous thromboembolism VTE
NewsFeed